ResearcherGerman Cancer Research CenterActive in the last 2 years
Nils Cordes
Matched on ORCID iD 0000-0001-5684-629X; OpenAlex author ID A5039794800. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 0, last author 5)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 8
2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: 2 papers · 2023: none · 2024: none · 2025: 1 paper
Papers 7
- Correction: Lan et al. CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer. Cancers 2022, 14, 326. Co-author DOI 10.3390/cancers17193181↗
- Therapy-Naive and Radioresistant 3-Dimensional Pancreatic Cancer Cell Cultures Are Effectively Radiosensitized by β1 Integrin Targeting. Last author DOI 10.1016/j.ijrobp.2021.08.035↗
- CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer. Co-author DOI 10.3390/cancers14020326↗
- Correction: Görte et al. Comparative Proton and Photon Irradiation Combined with Pharmacological Inhibitors in 3D Pancreatic Cancer Cultures. Cancers 2020, 12,… Last author DOI 10.3390/cancers13133364↗
- Comparative Proton and Photon Irradiation Combined with Pharmacological Inhibitors in 3D Pancreatic Cancer Cultures. Last author DOI 10.3390/cancers12113216↗
- β8 Integrin Mediates Pancreatic Cancer Cell Radiochemoresistance. Last author DOI 10.1158/1541-7786.mcr-18-1352↗
- LIM-only protein FHL2 critically determines survival and radioresistance of pancreatic cancer cells. Last author DOI 10.1016/j.canlet.2015.04.019↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Josephine Görte · 3 shared papers, 2020–2022 · strength 0.61
- Paper Therapy-Naive and Radioresistant 3-Dimensional Pancreatic Cancer Cell Cultures Are Effectively Radiosensitized by β1 In… DOI 10.1016/j.ijrobp.2021.08.035↗
- Paper Correction: Görte et al. Comparative Proton and Photon Irradiation Combined with Pharmacological Inhibitors in 3D Pancr… DOI 10.3390/cancers13133364↗
- Paper Comparative Proton and Photon Irradiation Combined with Pharmacological Inhibitors in 3D Pancreatic Cancer Cultures. DOI 10.3390/cancers12113216↗
- Erik H.J. Danen · 3 shared papers, 2020–2022 · strength 0.61
- Paper Therapy-Naive and Radioresistant 3-Dimensional Pancreatic Cancer Cell Cultures Are Effectively Radiosensitized by β1 In… DOI 10.1016/j.ijrobp.2021.08.035↗
- Paper Correction: Görte et al. Comparative Proton and Photon Irradiation Combined with Pharmacological Inhibitors in 3D Pancr… DOI 10.3390/cancers13133364↗
- Paper Comparative Proton and Photon Irradiation Combined with Pharmacological Inhibitors in 3D Pancreatic Cancer Cultures. DOI 10.3390/cancers12113216↗
- Christian P. Pilarsky · 3 shared papers, 2019–2025 · strength 0.49
- Paper Correction: Lan et al. CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Ca… DOI 10.3390/cancers17193181↗
- Paper CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer. DOI 10.3390/cancers14020326↗
- Paper β8 Integrin Mediates Pancreatic Cancer Cell Radiochemoresistance. DOI 10.1158/1541-7786.mcr-18-1352↗
- Bin Lan · 2 shared papers, 2022–2025 · strength 0.37
- Nathalie Britzen‐Laurent · 2 shared papers, 2022–2025 · strength 0.37
- Robert Grützmann · 2 shared papers, 2022–2025 · strength 0.37
- Sha Jin · 1 shared paper, 2019 · strength 0.12
- Elisa Zienert · 1 shared paper, 2015 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.